Table 1 Demographics
| Â | Celecoxib Dose | |
|---|---|---|
| Â | 200 mg twice daily | 400 mg twice daily |
| Â | NAF (plasma) | NAF(plasma) |
Samples | 19 (20) | 22 (260 |
Age (years) | Â | Â |
   Median | 48 (47) | 50.5 (50.5) |
   Range | 23–68 (23–68) | 30–81 (30–81) |
Premenopausal | 5 (6) | 11 (11) |
Race | Â | Â |
   White | 19 (20) | 40 (45) |
   Black | 0 | 0 |
   Asian | 0 | 0 |
   American Indian | 0 | 1 (1) |
Primary Risk Factors for Enrollment | Â | Â |
   Family History | 11 (11) | 14 (17) |
   Hyperplasia with/without atypia | 3 (3) | 6 (6) |
   History of Breast Cancer | 3 (3) | 3 (3) |
   History Prior Breast Biopsy | 2 (3) | 0 |